Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of CD73 Inhibitors" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about CD73 Inhibitors...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Nectin-4-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of EpCAM-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Her3-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Mesothelin-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
-
Dublin, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The "PD-1 Resistant Head and Neck Cancer - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
-
Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Desmoid Tumors Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" has been added to ...
-
Zurletrectinib demonstrated well-tolerated safety and promising antitumor activity in pediatric/adolescent patients with NTRK/ROS1-altered solid tumors.
-
Die Center Certification Ceremony fand am 4. Oktober 2025 anlässlich der Jahreskonferenz der European Association of Nuclear Medicine (EANM) in Barcelona statt. 9. Oktober 2025 – Wiesbaden,...